# US 2001/0025046 A1 · Self-emulsifying systems containing anticancer medicament

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0025046 A1
- Document ID: US20010025046A1
- Status: Published application
- Kind: A1
- Application number: 09/339,595
- Filed: 1999-06-24
- Published: 2001-09-27
- Earliest claimed: 1999-06-24
- Inventors: RONG(RON) LIU; ZHENG WANG
- Web page: https://patentgrep.com/patent/US20010025046A1

## CPC

- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/4858: {Organic compounds}
- A61K 31/336: having three-membered rings, e.g. oxirane, fumagillin
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a stabilized self-emulsifying system, comprising a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier and a stabilizing component, wherein the pharmaceutically acceptable carrier comprises an oily constituent and at least one surfactant. The stabilizing component comprises from about 1% to about 15% water relative to the weight of the self-emulsifying system, an acid, an adsorbent, or a complex-forming agent.

## Claims

### Claim 1

A stabilized self-emulsifying system, comprising a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier and a stabilizing component, wherein the pharmaceutically acceptable carrier comprises an oily constituent and at least one surfactant and the stabilizing component comprises from about 1% to about 15% water relative to the weight of the stabilized self-emulsifying system.

### Claim 2 (depends on 1)

The stabilized self-emulsifying system according to claim 1, wherein the stabilizing component comprises from about 2% to about 10% water.

### Claim 3 (depends on 2)

The stabilized self-emulsifying system according to claim 2, wherein the stabilizing component comprises from about 7.0% to about 7.5% water.

### Claim 4

A stabilized self-emulsifying system, comprising a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier and a stabilizing component, wherein the pharmaceutically acceptable carrier comprises an oily constituent and at least one surfactant and the stabilizing component comprises an acid.

### Claim 5 (depends on 4)

The stabilized self-emulsifying system according to claim 4, wherein the acid is an organic or an inorganic acid.

### Claim 6 (depends on 5)

The stabilized self-emulsifying system according to claim 5, wherein the organic acid is selected from the group consisting of aliphatic carboxylic acids, aromatic carboxylic acids, and sulfonic acids.

### Claim 7 (depends on 6)

The stabilized self-emulsifying system according to claim 6, wherein the organic acid is selected from the group consisting of aminobenzoic acid, benzoic acid, acetylsalicylic acid, salicylic acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, glycolic acid, lactic acid, malic acid, citric acid, methanesulfonic acid, 2-propanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, and p-toluenesulfonic acid.

### Claim 8 (depends on 7)

The stabilized self-emulsifying system according to claim 7, wherein the acid is citric acid.

### Claim 9 (depends on 5)

The stabilized self-emulsifying system according to claim 5, wherein the inorganic acid is selected from the group consisting of orthophosphoric acid, polyphosphoric acid, pyrophosphoric acid, and hydrochloric acid.

### Claim 10 (depends on 4)

The stabilized self-emulsifying system according to claim 4, wherein the stabilizing component comprises from about 0.005% to about 5.0% acid.

### Claim 11 (depends on 10)

The stabilized self-emulsifying system according to claim 10, wherein the stabilizing component comprises from about 0.05% to about 1.0% acid.

### Claim 12

A stable drug system comprising a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier and a stabilizing component, wherein the pharmaceutically acceptable carrier comprises an oily constituent and at least one surfactant and the stabilizing component is an adsorbent or complex-forming agent.

### Claim 13 (depends on 12)

The stabilized self-emulsifying system according to claim 12, wherein the stabilizing component is selected from the group consisting of gelatin, active charcoal, and silica gel.

### Claim 14 (depends on 12)

The stabilized self-emulsifying system according to claim 12, wherein the stabilizing component is a chelate or salt of ethylenediaminetetraacetic acid.

### Claim 15 (depends on 13)

The stabilized self-emulsifying system according to claim 13, wherein the stabilizing component is gelatin.

### Claim 16 (depends on 12)

The stabilized self-emulsifying system according to claim 12, wherein the stabilizing component comprises from about 0.01% to about 15% of the adsorbent or complex-forming agent.

### Claim 17 (depends on 16)

The stabilized self-emulsifying system according to claim 16, wherein the stabilizing component comprises from about 0.05% to about 10% of the adsorbent or complex-forming agent.

### Claim 18 (depends on 1)

The stabilized self-emulsifying system according to claim 1, wherein the oily component is a non-surface active oil.

### Claim 19 (depends on 1)

The stabilized self-emulsifying system according to claim 1, wherein the oily component is selected from Captex 100, Captex 300, Captex 355, Miglyol 810, Miglyol 812, Miglyol 818, Miglyol 829, and Dynacerin 660.

### Claim 20 (depends on 1)

The stabilized self-emulsifying system according to claim 1, wherein the self-emulsifying system is suitable for oral, enteral, parenteral, and intravenous administration.

### Claim 21 (depends on 4)

The stabilized self-emulsifying system according to claim 4, wherein the self-emulsifying system is suitable for oral, enteral, parenteral, and intravenous administration.

### Claim 22 (depends on 12)

The stabilized self-emulsifying system according to claim 12, wherein the self-emulsifying system is suitable for oral, enteral, parenteral, and intravenous administration.

### Claim 23

A pharmaceutical composition comprising a therapeutically active amount of o-(chloroacetylcarbamoyl)fumigillol, an oily constituent, at least one surfactant, and stabilizing component, wherein the stabilizing component is selected from about 1 to about 15 weight percent water; from about 0.005 to about 5.0 weight percent acid; and 0.05 to about 15 weight percent of an adsorbent or complex-forming agent.

### Claim 24 (depends on 23)

The composition according to claim 23, comprising from 40 to 60 weight percent of the oily component; from 20 to 40 weight percent surfactant; from 4 to 20 weight percent co-surfactant, and from 2 to about 12 weight percent water.

### Claim 25 (depends on 24)

The composition according to claim 24, wherein the composition comprises from about 7.0 to about 7.5 weight percent water.

### Claim 26 (depends on 23)

The composition according to claim 23, comprising from 40 to 60 weight percent of the oily component; from 20 to 40 weight percent surfactant; from 4 to 20 weight percent co-surfactant; and from 0.005 to about 5.0 weight percent acid.

### Claim 27 (depends on 26)

The composition according to claim 26, wherein the composition comprises from about 0.05 to about 1.0 weight percent acid.

### Claim 28 (depends on 23)

The composition according to claim 23, comprising from 40 to 60 weight percent of the oily component; from 20 to 40 weight percent surfactant; from 4 to 20 weight percent co-surfactant; and from 0.05 to about 15 weight percent.

### Claim 29 (depends on 28)

The composition according to claim 28, wherein the composition comprises from about 0.05 to about 10 weight percent of the adsorbent or complex-forming agent.

### Claim 30 (depends on 1)

A method of suppressing cell proliferation and neovascularization comprising administering the self-emulsifying system of claim 1.

### Claim 31 (depends on 4)

A method of suppressing cell proliferation and neovascularization comprising administering the stabilized self-emulsifying system of claim 4.

### Claim 32 (depends on 10)

A method of suppressing cell proliferation and neovascularization comprising administering the stabilized self-emulsifying system of claim 10.
